Tuberculosis, now largely controlled in the industrialized world, remains a stubbornly persistent killer in most of Africa, as well as parts of Asia and South America. The spread of multidrug-resistant strains of TB has slowed progress against the devastating disease, which is estimated to strike more than 10 million people annually.
But a modified soft-drink cooler, developed by researchers at MIT’s D-Lab, could make a dent in the disease’s impact. There are two key issues that physicians confront in trying to tackle drug-resistant TB strains in developing countries.
